2009
DOI: 10.1042/bj20081318
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis and specificity of human otubain 1-mediated deubiquitination

Abstract: OTUB (otubain) 1 is a human deubiquitinating enzyme that is implicated in mediating lymphocyte antigen responsiveness, but whose molecular function is generally not well defined. A structural analysis of OTUB1 shows differences in accessibility to the active site and in surface properties of the substrate-binding regions when compared with its close homologue, OTUB2, suggesting variations in regulatory mechanisms and substrate specificity. Biochemical analysis reveals that OTUB1 has a preference for cleaving L… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
225
0
4

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 181 publications
(236 citation statements)
references
References 47 publications
7
225
0
4
Order By: Relevance
“…[41][42][43] Although our immunoprecipitation experiments demonstrate that OTUB1 and YB-1 act in close proximity to each other, we currently cannot differentiate which of these two alternative mechanisms inhibit ubiquitination of YB-1. Interestingly, OTUB1 has been proposed to preferentially inhibit K48-linked ubiquitination, 40,44 which may specifically avert proteasomal degradation of target proteins, such as YB-1, while still allowing other ubiquitinationdependent processes. Future studies are required to decipher the concise molecular nature of the OTUB1 and YB-1 interaction and the consequences for YB-1 abundance, localization, and activity.…”
Section: Discussionmentioning
confidence: 99%
“…[41][42][43] Although our immunoprecipitation experiments demonstrate that OTUB1 and YB-1 act in close proximity to each other, we currently cannot differentiate which of these two alternative mechanisms inhibit ubiquitination of YB-1. Interestingly, OTUB1 has been proposed to preferentially inhibit K48-linked ubiquitination, 40,44 which may specifically avert proteasomal degradation of target proteins, such as YB-1, while still allowing other ubiquitinationdependent processes. Future studies are required to decipher the concise molecular nature of the OTUB1 and YB-1 interaction and the consequences for YB-1 abundance, localization, and activity.…”
Section: Discussionmentioning
confidence: 99%
“…For modeling of the PTEN/RPA and PTEN/OTUB1 complexes, we separately submitted the crystal structure of PTEN (PDB:1D5R) as a receptor and RPA RPA1(439-616)/RPA2(43-171)/RPA3 [23] or OTUB1 (PDB: 2ZFY) [28] as ligand to the web-based ClusPro2.0 docking server (http://cluspro.bu.edu/). This docking program filters docked conformations with good surface and charge complementarity and ranks them based on their clustering properties [25].…”
Section: In Silico Dockingmentioning
confidence: 99%
“…To confirm the structural linkage of these molecules, in silico analysis was used to evaluate docking of elements of the OTUB1 structure [28] with the PTEN crystal structure [24]. In the PTEN/OTUB1 complex, OTUB1 binds to the PTEN C2 domain through complimentary electrostatic charge distributions to within a distance of 3.0 Å (Supplementary information, Figure S4F; PTEN is in green and OTUB1 in yellow).…”
Section: Pten Regulates Rpa1 Deubiquitination By Recruiting Otub1mentioning
confidence: 99%
“…Therefore, it is likely that their activity, target recognition as well as subcellular localization are tightly regulated. OTUB1 protein is detected ubiquitously in tissues and recent reports have shed light into the molecular functions of OTUB1 in deubiquitylating K48-linked ubiquitin chains as well as inhibiting the action of E2 ubiquitin-conjugating enzymes (1,(3)(4)(5)(6)(7)(8)(9)(10). OTUB1 has been reported to target many proteins for deubiquitylation, including TNF receptor-associated factors 3/6 (TRAF3/6) (11), estrogen receptor α (ERα) (12), the tumor suppressor protein p53 (13), and the cellular inhibitor of apoptosis c-IAP1 (14).…”
Section: Introductionmentioning
confidence: 99%